Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Consulting Cardiologists Face an Imaging Paradigm Shift

By HospiMedica International staff writers
Posted on 22 Mar 2017
In response to the rapid and unsustainable growth in the use of cardiac imaging procedures, the U.S. More...
Centers for Medicare & Medicaid Service 2017 Medicare Physician Fee Schedule (MPFS) has confirmed the January 1, 2018, deadline for physicians to begin reporting on appropriate use criteria (AUC) interactions in order to receive payment for Medicare advanced imaging, as mandated by the Protecting Access to Medicare Act (PAMA) of 2014.

The AUC will serve as a guide for physicians to incorporate symptoms, risk factors, and clinical history in selecting the patients for whom testing is most appropriate, based on the best available evidence or expert consensus. AUC will also be part of a patient’s comprehensive disease management plan in order to maximize the value of care by minimizing unnecessary imaging and resultant downstream invasive procedures. It will thus help to avoid excess costs, enhances the value of imaging in risk stratification and decision-making, and reduce radiation risk, particularly in women.

The AUC will help physicians steer patients to alternative tests, or no testing at all, by classifying testing across a range of clinical scenarios in three categories: “appropriate” (established value); “may be appropriate” (uncertain value); and “rarely appropriate” (no clear value). From 2018, physicians will be required to use a clinical decision-support mechanisms (CDSM) for AUC consultation when ordering advanced imaging procedures, such as radionuclide imaging, magnetic resonance imaging (MRI), and computed tomography (CT); but other procedures, such as echocardiography, will be exempt.

“With the PAMA change, a massive shift will occur, wherein the burden of reducing inappropriate use moves largely from payers to providers. Most physicians are unprepared for this paradigm shift,” said Rami Doukky, MD, of John H. Stroger Jr. Hospital (Chicago, IL, USA), and colleagues, in an opinion piece published on February 28, 2017, in Annals of Internal Medicine. “Currently available CDSMs are often disjointed from the care process, and need to be integrated more seamlessly into EHR systems to provide real-time guidance with the least provider burden.”

Professional organizations such as the American College of Cardiology and the American College of Radiology have established multidisciplinary autonomous teams for rigorous, systematic review of published literature and consensus guidelines in order to construct detailed AUCs, with transparency of the methodology supporting appropriate use determination, and full disclosure of potential conflicts of interest. Radiology benefits management programs and insurance companies are specifically excluded from this process.


Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Surgical System
Stealth AXiS
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.